PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%

PLx Pharma Inc. (PLXP) reported Friday a second-quarter net loss attributable to common shareholders of $11.56 million or $0.43 per share, narrower than $18.71 million or $0.79 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/uFeo2Qf
via IFTTT